anticancer/gin diare

Lyen an sove nan clipboard la

Chwazi kalite sòt

8 rezilta yo

Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION The invention relates generally to the use of sesquiterpene lactones in the treatment of infections caused by Flaviviridae and, more specifically, to the use of sesquiterpene lactone endoperoxides to treat hepatitis C infections, yellow fever, dengue fever, bovine viral

Compositions of novel opioid compounds and method of use thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Technical Field This invention relates generally to diarylmethylpiperazine compounds useful as mu and/or delta receptor opioid compounds and pharmaceuticals containing same that may be useful for mediating analgesia, combating drug addiction, alcohol addiction, drug

Selective opioid compounds

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD This invention relates to morphinan compounds useful as .mu., .kappa. and/or .delta. receptor opioid compounds and pharmaceuticals containing same that may be useful for mediating analgesia, combating drug addiction, alcohol addiction, drug overdose, mental illness, bladder

Selective opioid compounds

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The present invention relates to novel conformationally-defined macrocyclic compounds that bind to and/or are functional modulators of the motilin receptor including subtypes, isoforms and/or variants thereof. These macrocyclic compounds possess appropriate pharmacological

Fusion polypeptide containing GLP and immunoglobulin hybrid Fc and use thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/KR2015/014542 filed Dec. 31, 2015, claiming priority based on Korean Patent Application No. 10-2014-0195793, filed Dec. 31, 2014, the contents of all of which are incorporated herein by

Apoptosis inhibitors

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION Cancer is a leading cause of death in the United States. For example in 1998, an estimated 185,000 men were diagnosed with prostate cancer, and more than 39,000 men died of the disease. See, S. H. Landis et al., CA Cancer J. Clin. 48, 6, 1998. Although survival rates for

Agents for alleviating side effects

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This application is a 371 of PCT/JP00/01607 filed Mar. 16, 2000. TECHNICAL FIELD The present invention relates to an agent for alleviating side effects caused by use of an anti-tumor agent. BACKGROUND ART Most drugs employed in chemotherapy to treat cancers act upon proliferating cells to arrest the

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye